These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32703679)

  • 1. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
    Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
    Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.
    Shariq OA; Lines KE; English KA; Jafar-Mohammadi B; Prentice P; Casey R; Challis BG; Selberherr A; Boon H; Cranston T; Ryan FJ; Mihai R; Healy U; Kurzawinski T; Dattani MT; Bancos I; Dy BM; Lyden ML; Young WF; McKenzie TJ; Richards D; Thakker RV
    Surgery; 2022 Jan; 171(1):77-87. PubMed ID: 34183184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
    Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
    Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
    Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
    Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the clinical management of multiple endocrine neoplasia type 1.
    Pieterman CRC; Valk GD
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
    Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
    Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
    Cho YY; Chung YJ
    Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Vialon M; Desailloud R; Caron P
    Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S19-S28. PubMed ID: 31606058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.
    Horiuchi K; Okamoto T; Iihara M; Tsukada T
    Surg Today; 2013 Aug; 43(8):894-9. PubMed ID: 23052745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis,
    Carsote M; Nistor C; Gheorghe AM; Sima OC; Trandafir AI; Nistor TVI; Sandulescu BA; Ciobica ML
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.
    Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML
    Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of multiple endocrine neoplasia type 1.
    Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
    Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
    Ramamoorthy B; Nilubol N
    Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.